Structure |
Chemical Name |
CAS |
MF |
![Carvedilol Impurity 2](/CAS/20200611/GIF/1198090-71-9.gif) |
Carvedilol Impurity 2 |
1198090-71-9 |
C18H17NO3 |
![Clotrimazole Impurity 2](/) |
Clotrimazole Impurity 2 |
|
|
![Dapagliflozin Impurity 33](/) |
Dapagliflozin Impurity 33 |
|
|
![Erlotinib Impurity 56](/) |
Erlotinib Impurity 56 |
|
|
![Moxifloxacin Impurity 8](/CAS/20210111/GIF/1829588-19-3.gif) |
Moxifloxacin Impurity 8 |
1829588-19-3 |
C21H25N3O5 |
![Olaparib Impurity 30](/CAS/20210111/GIF/1460272-52-9.gif) |
Olaparib Impurity 30 |
1460272-52-9 |
C24H21FN4O4 |
![Pitavastatin Impurity 27](/) |
Pitavastatin Impurity 27 |
|
|
![Pramipexole Impurity 24](/) |
Pramipexole Impurity 24 |
|
|
![Rocuronium Bromide Impurity 22](/) |
Rocuronium Bromide Impurity 22 |
|
|
![Tolterodine Impurity 1](/CAS/20200331/GIF/CB54821015.gif) |
Tolterodine Impurity 1 |
88407-28-7 |
C22H31NO |
![Voriconazole Impurity 7](/CAS/20211123/GIF/239807-04-6.gif) |
Voriconazole Impurity 7 |
239807-04-6 |
C16H14F3N5O |
![AZD9291 Osimertinib Impurity 3](/) |
AZD9291 Osimertinib Impurity 3 |
|
|
![Dextrorotation lansoprazole Impurity K](/) |
Dextrorotation lansoprazole Impurity K |
|
|
![Doxofylline Impurity A](/) |
Doxofylline Impurity A |
|
|
![lansoprazole Impurity 24](/) |
lansoprazole Impurity 24 |
|
|
![lansoprazole Impurity 30](/) |
lansoprazole Impurity 30 |
|
|
![meta-dyhydroxy Sugammadex sodium Impurity 2](/) |
meta-dyhydroxy Sugammadex sodium Impurity 2 |
|
|
![Palbociclib Impurity 29](/) |
Palbociclib Impurity 29 |
|
|
![Palbociclib Impurity 34](/) |
Palbociclib Impurity 34 |
|
|
![Ropivacaine Impurity 38](/) |
Ropivacaine Impurity 38 |
|
|
![Ropivacaine Impurity 43](/) |
Ropivacaine Impurity 43 |
2726971-51-1 |
|
![Sugammadex sodium Decomposition process Impurity 1](/) |
Sugammadex sodium Decomposition process Impurity 1 |
|
|
![Sugammadex sodium Org198786-1 Impurity](/) |
Sugammadex sodium Org198786-1 Impurity |
|
|
![Sugammadex sodium starting material Impurity 1](/) |
Sugammadex sodium starting material Impurity 1 |
|
|
![Fludarabine EP impurity H](/CAS/20210111/GIF/548774-57-8.gif) |
Fludarabine EP impurity H |
548774-57-8 |
C10H10FN5O3 |
![Butyphthalide impurity 30](/) |
Butyphthalide impurity 30 |
|
|
![Cabozantinib impurity S](/) |
Cabozantinib impurity S |
|
|
![Ticagrelor Impurity 39](/) |
Ticagrelor Impurity 39 |
|
|
![Tofacitinib Impurity 109](/) |
Tofacitinib Impurity 109 |
|
|
![Tofacitinib Impurity 114](/) |
Tofacitinib Impurity 114 |
|
|
![Vildagliptin Impurity 34](/CAS/20210111/GIF/1824265-77-1.gif) |
Vildagliptin Impurity 34 |
1824265-77-1 |
C10H17NO3 |
![1-(3-(benzyloxy)-5-hydroxyphenyl)-2-(tert-butylamino)ethan-1-one](/CAS/20200331/GIF/CB54908512.gif) |
1-(3-(benzyloxy)-5-hydroxyphenyl)-2-(tert-butylamino)ethan-1-one |
2459974-72-0 |
C19H23NO3 |
![Demeclocycline EP Impurity C](/CAS/20210111/GIF/129044-45-7.gif) |
Demeclocycline EP Impurity C |
129044-45-7 |
C21H22N2O8 |
![Brimonidine Impurity D](/) |
Brimonidine Impurity D |
|
|
![Esmolol impurity D](/) |
Esmolol impurity D |
|
|
![Diquafosol Impurity D](/) |
Diquafosol Impurity D |
|
|
![Peramivir Impurity 11](/) |
Peramivir Impurity 11 |
|
|
![Vildagliptin Impurity 6](/) |
Vildagliptin Impurity 6 |
|
|
![Sunitinib Impurity 1](/) |
Sunitinib Impurity 1 |
|
|
![Erlotinib Impurity 18](/) |
Erlotinib Impurity 18 |
|
|
![Fasudil Impurity 6](/CAS/20211123/GIF/1581642-06-9.gif) |
Fasudil Impurity 6 |
1581642-06-9 |
C14H18ClN3O2S |
![Rosuvastatin Impurity 56](/) |
Rosuvastatin Impurity 56 |
|
|
![Dapoxetine Impurity 4](/) |
Dapoxetine Impurity 4 |
|
|
![Ticagrelor Impurity 17](/) |
Ticagrelor Impurity 17 |
|
|
![Empagliflozin Impurity 13](/) |
Empagliflozin Impurity 13 |
|
|
![Moxifloxacin Impurity 2](/) |
Moxifloxacin Impurity 2 |
|
|
![Cabozantinib Impurity 1](/) |
Cabozantinib Impurity 1 |
|
|
![Febuxostat Impurity 56](/) |
Febuxostat Impurity 56 |
|
|
![Ambroxol Impurity 9 HCl](/) |
Ambroxol Impurity 9 HCl |
|
|
![Penicillin Impurity A](/) |
Penicillin Impurity A |
|
|
![Cefminox Sodium impurity A](/) |
Cefminox Sodium impurity A |
|
|
![Cefotiam Impurity A](/) |
Cefotiam Impurity A |
|
|
![pranoprofen impurity 25](/) |
pranoprofen impurity 25 |
|
|
![Peramivir Impurity D](/) |
Peramivir Impurity D |
|
|
![Lincomycin sulfoxide Impurity 2](/) |
Lincomycin sulfoxide Impurity 2 |
|
|
![Lincomycin sulfoxide Impurity E](/) |
Lincomycin sulfoxide Impurity E |
|
|
![Fasudil iMpurity E](/) |
Fasudil iMpurity E |
|
|
![(+/-)-EPINEPHRINE SULFONIC ACID](/CAS/GIF/26405-77-6.gif) |
(+/-)-EPINEPHRINE SULFONIC ACID |
26405-77-6 |
C9H13NO5S |
![GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT)](/CAS/20180808/GIF/112188-16-6.gif) |
GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) |
112188-16-6 |
C14H22GdN4O6 |
![((R)-2-biphenyl-4-yl-1-forMylethyl)carbaMic acid t-butyl ester](/CAS/20150408/GIF/149709-58-0.gif) |
((R)-2-biphenyl-4-yl-1-forMylethyl)carbaMic acid t-butyl ester |
149709-58-0 |
C20H23NO3 |
![1-(2,3-DiMethylphenyl)-1-(1H-iMidazol-4-yl)ethanol](/CAS/20150408/GIF/86347-12-8.gif) |
1-(2,3-DiMethylphenyl)-1-(1H-iMidazol-4-yl)ethanol |
86347-12-8 |
C13H16N2O |
![(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one](/CAS/20150408/GIF/CB72735602.gif) |
(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
1612153-32-8 |
C20H20FNO4 |
![(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one](/CAS/20150408/GIF/528565-93-7.gif) |
(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
528565-93-7 |
C20H20FNO4 |
![Posaconazole iMpurity 3](/) |
Posaconazole iMpurity 3 |
|
|
![Bezafibrate Impurity D](/CAS/20210111/GIF/41859-58-9.gif) |
Bezafibrate Impurity D |
41859-58-9 |
C21H24ClNO4 |
![Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers)](/CAS/20200611/GIF/1642559-64-5.gif) |
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers) |
1642559-64-5 |
C18H20ClN3O4S |
![Ezetimibe Related Impurity 37](/CAS/20200611/GIF/204589-68-4.gif) |
Ezetimibe Related Impurity 37 |
204589-68-4 |
C24H19F2NO2 |
![S, R-Isovalganciclovir Impurity](/CAS/20180808/GIF/1356932-18-7.gif) |
S, R-Isovalganciclovir Impurity |
1356932-18-7 |
C14H22N6O5 |
![Sofosbuvir Impurity 8](/CAS/20200611/GIF/944476-44-2.gif) |
Sofosbuvir Impurity 8 |
944476-44-2 |
C24H22N2O8 |
![1-((2'-cyanobiphenyl-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid](/CAS/20180703/GIF/1098100-87-8.gif) |
1-((2'-cyanobiphenyl-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid |
1098100-87-8 |
C26H23N3O2 |
![Fimasartan Impurity](/) |
Fimasartan Impurity |
|
|
![2-(((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)(methyl)amino)succinic acid](/CAS/20180703/GIF/CB72750072.gif) |
2-(((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)(methyl)amino)succinic acid |
|
C21H20FN3O6S |
![2-(DIETHYLAMINO)-N-(2,4-DIMETHYLPHENYL)ACETAMIDE](/CAS/20180703/GIF/17289-53-1.gif) |
2-(DIETHYLAMINO)-N-(2,4-DIMETHYLPHENYL)ACETAMIDE |
17289-53-1 |
C14H22N2O |
![(3RS)-3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one](/CAS/20180703/GIF/CB72920112.gif) |
(3RS)-3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
|
C16H20N2O |
![Oxaliplatin impurity](/) |
Oxaliplatin impurity |
|
|
![NiMesulide EP IMpurity](/CAS/20200515/GIF/38880-53-4.gif) |
NiMesulide EP IMpurity |
38880-53-4 |
C7H8N2O5S |
![Moxifloxacin Impurities](/) |
Moxifloxacin Impurities |
|
|
![Parecoxib Impurity K](/CAS/20200611/GIF/198471-69-1.gif) |
Parecoxib Impurity K |
198471-69-1 |
C17H16N2O3S |
![Linagliptin Impurity K](/CAS/20200611/GIF/1638744-06-5.gif) |
Linagliptin Impurity K |
1638744-06-5 |
C25H29BrN8O2 |
![(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile](/CAS/20180703/GIF/CB73042202.gif) |
(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
1917324-13-0 |
C31H28F2N8O4 |
![L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1)](/CAS/20211123/GIF/1194550-65-6.gif) |
L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1) |
1194550-65-6 |
C27H27Cl3N2O5S |
![Etoricoxib Impurity 14](/) |
Etoricoxib Impurity 14 |
|
|
![Riociguat Impurtiy 3](/) |
Riociguat Impurtiy 3 |
|
|
![Trelagliptin Impurity 2](/) |
Trelagliptin Impurity 2 |
|
|
![Chlorhexidine Impurity B](/CAS/20200611/GIF/1308292-89-8.gif) |
Chlorhexidine Impurity B |
1308292-89-8 |
C16H26ClN9O |
![Dapoxetine Impurity D](/) |
Dapoxetine Impurity D |
|
|
![Exemestane Impurity 1](/CAS/20211123/GIF/159354-61-7.gif) |
Exemestane Impurity 1 |
159354-61-7 |
C20H24O3 |
![Lidocaine Impurity](/CAS/20180906/GIF/35891-84-0.gif) |
Lidocaine Impurity |
35891-84-0 |
C11H16N2O.ClH |
![Pramipexole Impurity J](/) |
Pramipexole Impurity J |
|
|
![Solifenacin Related Compound 14](/CAS/20200515/GIF/605696-10-4.gif) |
Solifenacin Related Compound 14 |
605696-10-4 |
C25H30N2O2 |
![4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one](/CAS/20180703/GIF/160552-54-5.gif) |
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
160552-54-5 |
C8H11N3O4S |
![8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one](/CAS/20180703/GIF/869478-13-7.gif) |
8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one |
869478-13-7 |
C28H32N2O5 |
![1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/CAS/20180703/GIF/743460-48-2.gif) |
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
743460-48-2 |
C21H27N3O2 |
![Cefuroxime Sodium impurity D](/CAS/20180703/GIF/CB73053631.gif) |
Cefuroxime Sodium impurity D |
|
C16H16N4NaO8S |
![Silodosin impurity A](/) |
Silodosin impurity A |
|
|
![cefditoren △-3 isomer](/) |
cefditoren △-3 isomer |
|
|
![Ixazomib Impurity 1](/CAS/20180808/GIF/1201903-02-7.gif) |
Ixazomib Impurity 1 |
1201903-02-7 |
C24H33BCl2N2O4 |
![(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid](/CAS/20180703/GIF/1026952-91-9.gif) |
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
1026952-91-9 |
C13H11F2NO4 |
![((4-Methoxyphenoxy)methylene)dibenzene](/CAS/20180703/GIF/85686-16-4.gif) |
((4-Methoxyphenoxy)methylene)dibenzene |
85686-16-4 |
C20H18O2 |
![Tofacitinib Impurity L](/) |
Tofacitinib Impurity L |
|
|